| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
137,176 |
121,853 |
$10.80M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,792 |
11,711 |
$3.06M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,512 |
18,179 |
$2.52M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,842 |
31,147 |
$1.13M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,130 |
9,518 |
$1.06M |
| 36415 |
Collection of venous blood by venipuncture |
47,192 |
42,470 |
$999K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
14,676 |
3,622 |
$642K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,981 |
3,877 |
$466K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,992 |
2,816 |
$376K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,336 |
5,809 |
$296K |
| 99223 |
Prolong inpt eval add15 m |
2,046 |
1,918 |
$222K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,238 |
2,162 |
$157K |
| 99233 |
Prolong inpt eval add15 m |
2,485 |
864 |
$157K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
2,313 |
2,181 |
$154K |
| 80053 |
Comprehensive metabolic panel |
17,069 |
15,827 |
$153K |
| X5622 |
|
488 |
447 |
$113K |
| 90837 |
Psychotherapy, 53 minutes with patient |
676 |
344 |
$77K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,146 |
988 |
$75K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,110 |
1,912 |
$69K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,353 |
1,224 |
$60K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,240 |
3,162 |
$59K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,202 |
20,303 |
$58K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,145 |
1,089 |
$52K |
| 99222 |
Initial hospital care, per day, moderate complexity |
736 |
691 |
$51K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,628 |
2,577 |
$50K |
| 92557 |
|
670 |
650 |
$48K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,079 |
2,989 |
$48K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
10,389 |
8,785 |
$43K |
| 11721 |
|
1,638 |
1,462 |
$43K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
588 |
555 |
$39K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,019 |
988 |
$37K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,610 |
1,567 |
$34K |
| 71045 |
Radiologic examination, chest; single view |
549 |
518 |
$33K |
| 90832 |
Psychotherapy, 30 minutes with patient |
570 |
328 |
$32K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
618 |
532 |
$29K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
374 |
348 |
$22K |
| 80061 |
Lipid panel |
1,873 |
1,812 |
$22K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
91 |
38 |
$21K |
| 92567 |
|
1,181 |
1,149 |
$21K |
| 11056 |
|
155 |
135 |
$19K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
355 |
351 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,207 |
2,063 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,398 |
2,307 |
$16K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
91 |
51 |
$13K |
| 92504 |
|
1,085 |
946 |
$12K |
| 81001 |
|
5,611 |
5,267 |
$11K |
| 0002A |
|
528 |
502 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
190 |
177 |
$9K |
| 80306 |
|
691 |
595 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
284 |
267 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
529 |
492 |
$7K |
| 87631 |
|
270 |
266 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
284 |
267 |
$7K |
| 36416 |
|
134 |
130 |
$7K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
581 |
341 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
316 |
279 |
$6K |
| 73630 |
|
125 |
99 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
70 |
64 |
$6K |
| 84484 |
|
912 |
755 |
$6K |
| 92552 |
|
80 |
80 |
$6K |
| 99442 |
|
138 |
129 |
$5K |
| 86140 |
|
1,164 |
1,088 |
$5K |
| 83690 |
|
940 |
890 |
$5K |
| 99221 |
|
97 |
91 |
$5K |
| 83605 |
|
1,256 |
1,064 |
$5K |
| 92550 |
|
80 |
76 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
774 |
755 |
$5K |
| 97597 |
|
47 |
25 |
$4K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
24 |
13 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
51 |
28 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
699 |
682 |
$4K |
| 0001A |
|
277 |
258 |
$4K |
| 90686 |
|
711 |
694 |
$4K |
| 87210 |
|
453 |
418 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
25 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,170 |
1,048 |
$3K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
152 |
53 |
$3K |
| 85610 |
|
448 |
426 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
29 |
24 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
41 |
39 |
$3K |
| 31231 |
|
14 |
14 |
$3K |
| 86780 |
|
111 |
100 |
$3K |
| 92556 |
|
90 |
90 |
$3K |
| 77336 |
|
23 |
12 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,133 |
1,087 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,632 |
1,324 |
$2K |
| 99215 |
Prolong outpt/office vis |
29 |
27 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
67 |
66 |
$1K |
| 91320 |
|
29 |
28 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,249 |
1,167 |
$1K |
| 82077 |
|
145 |
133 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
206 |
189 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
879 |
421 |
$1K |
| 99441 |
|
47 |
45 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
48 |
48 |
$1K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
43 |
37 |
$1K |
| 90480 |
|
42 |
41 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
363 |
288 |
$960.71 |
| 87081 |
|
893 |
853 |
$943.71 |
| 83735 |
|
150 |
142 |
$856.13 |
| 85027 |
|
820 |
779 |
$851.80 |
| 0054A |
|
29 |
29 |
$841.28 |
| 0124A |
|
26 |
26 |
$812.25 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
18 |
$691.29 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
39 |
38 |
$542.01 |
| 0352U |
|
13 |
13 |
$503.52 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
685 |
628 |
$453.72 |
| J2704 |
Injection, propofol, 10 mg |
785 |
694 |
$435.81 |
| 86803 |
|
26 |
25 |
$413.34 |
| 0072A |
|
13 |
13 |
$384.86 |
| 0031A |
|
14 |
12 |
$383.95 |
| 0004A |
|
17 |
17 |
$361.91 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
38 |
36 |
$317.22 |
| 93016 |
|
28 |
27 |
$310.23 |
| 92551 |
|
27 |
27 |
$309.75 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
417 |
394 |
$303.92 |
| 83615 |
|
129 |
122 |
$286.28 |
| 83655 |
|
28 |
26 |
$228.81 |
| 74019 |
|
12 |
12 |
$223.82 |
| 86850 |
|
41 |
39 |
$220.27 |
| 93018 |
|
28 |
27 |
$205.93 |
| 82607 |
|
15 |
14 |
$194.40 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
39 |
39 |
$189.69 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
364 |
321 |
$148.29 |
| 96127 |
|
14 |
14 |
$139.88 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
46 |
40 |
$135.97 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
208 |
172 |
$126.00 |
| 90656 |
|
50 |
50 |
$109.82 |
| 88304 |
|
13 |
12 |
$106.08 |
| 82248 |
|
26 |
25 |
$101.82 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
85 |
53 |
$97.80 |
| 85379 |
|
17 |
15 |
$79.10 |
| 94726 |
|
13 |
13 |
$76.92 |
| 82570 |
|
40 |
37 |
$67.22 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
30 |
25 |
$65.81 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16 |
13 |
$65.01 |
| 81025 |
|
81 |
77 |
$60.88 |
| 94729 |
|
13 |
13 |
$56.51 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
12 |
12 |
$34.56 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
26 |
25 |
$11.88 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
12 |
$0.24 |
| 90677 |
|
40 |
39 |
$0.05 |
| 90697 |
|
12 |
12 |
$0.01 |
| 90670 |
|
17 |
17 |
$0.01 |
| 99000 |
|
189 |
183 |
$0.00 |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
12 |
12 |
$0.00 |
| 90633 |
|
25 |
25 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
53 |
50 |
$0.00 |
| 81003 |
|
15 |
15 |
$0.00 |
| 98940 |
|
36 |
24 |
$0.00 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
14 |
12 |
$0.00 |
| 93017 |
|
15 |
14 |
$0.00 |